The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme

Diabetic Medicine

Volumn 33, Issue 7, 2016, Pages 896-903

  Oke, J L ^a   Stratton, I M ^b   Aldington, S J ^b   Stevens, R J ^a   Scanlon, P H ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Gloucestershire Retinal Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C;

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HEALTH CARE QUALITY; HIDDEN MARKOV MODEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; REMISSION; RETINA MACULOPATHY; SCREENING; SEX DIFFERENCE;

EID: 84975123281     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13053     Document Type: Article

References (23)

1. Stratton IM, Aldington SJ, Taylor DJ, Adler AI, Scanlon PH. A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 2013; 36: 580–585.
2. Ruamviboonsuk P, Teerasuwanajak K, Tiensuwan M, Yuttitham K. Interobserver agreement in the interpretation of single-field digital fundus images for diabetic retinopathy screening. Ophthalmology 2006; 113: 826–832.
3. Milton RC, Ganley JP, Lynk RH. Variability in grading diabetic retinopathy from stereo fundus photographs: comparison of physician and lay readers. Br J Ophthalmol 1977; 61: 192–201.
4. Uhry Z, Hédelin G, Colonna M, Asselain B, Arveux P, Rogel A et al. Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res 2010; 19: 463–486.
5. Jackson CH, Sharples LD, Thompson SG, Duffy SW, Couto E. Multistate Markov Models for disease progression with classification error. J R Stat Soc Ser D (The Stat) 2003; 52: 193–209.
6. Bureau A, Shiboski S, Hughes JP. Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Stat Med 2003; 22: 441–462.
7. Kohner EM, Stratton IM, Aldington SJ, Turner RC, Matthews DR. Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group. Diabetologia 1999; 42: 1107–1112.
8. Jackson C. Multi-state modelling with R: the msm package. 2007. Available at http://www.leg.ufpr.br/lib/exe/fetch.php/projetos:msc:msm-manual.pdf Last accessed 21 December 2011.
9. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2015.
10. Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess 2015; 19: 1–116.
11. Zucchini W, MacDonald IL. Hidden Markov Models for Time Series. Boca Raton, FL: CRC Press, 2009.
12. Rabiner LR. A Tutorial on Hidden Markov Models and Selected Applications in Speech Recognition. Available at http://citeseer.ist.psu.edu/viewdoc/summary?doi=10.1.1.131.2084 Last accessed 7 September 2015.
13. Miller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Med Decis Mak 1994; 14: 52–58.
14. Titman AC. Model diagnostics in multi-state models of biological systems. PhD thesis, University of Cambridge, 2007. Available at http://www.maths.lancs.ac.uk/~titman/thesis.pdf Last accessed 7 September 2015.
15. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156–163.
16. Stellingwerf C, Hardus PLLJ, Hooymans JMM. Two-field photography can identify patients with vision-threatening diabetic retinopathy: a screening approach in the primary care setting. Diabetes Care 2001; 24: 2086–2090.
17. Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ 1995 Oct 28; 7013: 1131–1135. Available at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2551056&tool=pmcentrez&rendertype=abstract
18. Scanlon PH, Malhotra R, Greenwood RH, Aldington SJ, Foy C, Flatman M et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol 2003; 87: 1258–1263.
19. Olson JA, Strachan FM, Hipwell JH, Goatman KA, McHardy KC, Forrester JV et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med 2003; 20: 528–534.
20. Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Barned N et al. The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabet Med 2003; 20: 467–474.
21. Healy R, Sallam A, Jones V, Donachie PHJ, Scanlon PH, Stratton IM et al. Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathy. Eur J Ophthalmol 2014; 24: 550–558.
22. Manjunatha RS, Manjunatha NP, Baskar V, Headon MP, Singh BM, Viswanath a K. Quality assurance in the diabetic retinopathy screening programme: evaluating the benefit of universal regrading of the normal primary grade. Diabet Med; 29: 287–288.
23. Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 2013; 56: 1716–1725.